Merck Bolsters Oncology Pipeline with $2.13 Billion SciBrunch Licensing Deal for KRAS G12D Inhibitor
In a significant move to reshape its oncology portfolio ahead of impending patent cliffs, Merck & Co. has secured exclusive...
deal
Meta’s Strategic Pivot: Inside the Potential $10 Billion Cloud Infrastructure Deal with Anthropic
In a move that could fundamentally reshape the landscape of the artificial intelligence industry, Meta Platforms Inc. is reportedly in...
AstraZeneca Bolsters Oncology Franchise with $1.5 Billion Global Licensing Deal for Dizal’s Zegfrovy
In a major strategic maneuver that underscores the shifting landscape of global pharmaceutical partnerships, AstraZeneca has announced a definitive agreement...
